“Myxovirus Resistance, Osteopontin and Suppressor of Cytokine Signaling 3 Polymorphisms Predict Hepatitis C Virus Therapy Response in an Admixed Patient Population: Comparison With IL28B”. Clinics 68, no. 10 (October 1, 2013): 1325–1332. Accessed May 20, 2024. https://www.revistas.usp.br/clinics/article/view/77009.